These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32908896)

  • 1. Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis.
    Zhang Z; Zhang D; Cui Y; Qiu Y; Miao C; Lu X
    Biomed Res Int; 2020; 2020():5236236. PubMed ID: 32908896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a circulating microRNA signature for colorectal cancer detection.
    Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
    PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-451a regulates colorectal cancer proliferation in response to radiation.
    Ruhl R; Rana S; Kelley K; Espinosa-Diez C; Hudson C; Lanciault C; Thomas CR; Liana Tsikitis V; Anand S
    BMC Cancer; 2018 May; 18(1):517. PubMed ID: 29720118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X; Stock C; Burwinkel B; Brenner H
    PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
    Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.
    Farouk S; Khairy A; Salem AM; Soliman AF; Bader El Din NG
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):825-834. PubMed ID: 33290159
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
    Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.